Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Sleep Med ; 63: 41-45, 2019 11.
Article in English | MEDLINE | ID: mdl-31605903

ABSTRACT

STUDY OBJECTIVES: To identify a link between sleep disordered breathing, nocturnal hypoxemia, and lung cancer. METHODS: We conducted a cross-sectional study of a combined cohort of 302 individuals derived from the sleep apnea in lung cancer study (SAIL; NCT02764866) investigating the prevalence of sleep apnea in lung cancer, and the sleep apnea in lung cancer screening study (SAILS; NCT02764866) investigating the prevalence of sleep apnea in a lung cancer screening program. All subjects had spirometry and a chest CT, underwent home sleep apnea testing (HSAT), and completed a sleep related questionnaire. Subjects from the SAIL study underwent HSAT prior to initiating oncologic therapy or surgery. Subjects with an apnea-hypopnea index (AHI) > 15 were compared with a control group of individuals with an AHI < 15. Propensity score, near neighbor matching, and logistic regression adjusted for potential confounders, were used in order to evaluate the association between sleep apnea, the AHI, oxygen desaturation indices and lung cancer. RESULTS: The prevalence of sleep apnea and lung cancer in the combined cohort was 42% and 21%, respectively. Lung cancer was 8% more prevalent in patients with an AHI >15. The difference was statistically significant when assessed by propensity score matching (p = 0.015) and nearest neighbor matching (p = 0.041). Binary logistic regression adjusted for potential confounders revealed a statistically significant association between AHI (p = 0.04), nocturnal hypoxemia, including time spent below 90% oxyhemoglobin saturation (T90%; p = 0.005), 3% oxygen desaturation index (ODI3; p = 0.02) and lung cancer. CONCLUSIONS: Sleep apnea and nocturnal hypoxemia are associated with an increased prevalence of lung cancer. CLINICAL TRIAL REGISTRATION: SAIL study (NCT02764866) and SAILS study (NCT02764866).


Subject(s)
Hypoxia/epidemiology , Lung Neoplasms/epidemiology , Oxygen/metabolism , Sleep Apnea, Obstructive/epidemiology , Cohort Studies , Cross-Sectional Studies , Early Detection of Cancer , Female , Humans , Male , Middle Aged , Prevalence , Risk Factors , Surveys and Questionnaires
2.
Respiration ; 97(2): 119-124, 2019.
Article in English | MEDLINE | ID: mdl-30261487

ABSTRACT

BACKGROUND: Obstructive sleep apnea (OSA) has been linked to tumorigenesis and tumor progression. OBJECTIVES: The Sleep Apnea in Lung Cancer (SAIL) study (NCT02764866) was designed to determine the prevalence of OSA in patients with lung cancer. METHODS: Cross-sectional study including consecutive patients with newly diagnosed lung cancer. All patients were offered home sleep apnea testing (HSAT) and administered a sleep-specific questionnaire prior to initiating oncologic treatment. Sleep study-related variables, symptoms, and epidemiologic data as well as cancer related variables were recorded. RESULTS: Eighty-three patients were enrolled in the SAIL study. Sixty-six completed HSAT. The mean age was 68 ± 11 years and 58% were male with a mean body mass index of 28.1 ± 5.4. Forty-seven percent were current smokers, 42% former smokers, and 11% never smokers with a median tobacco consumption of 51 pack-years. Fifty percent had COPD with a mean FEV1 of 83 ± 22.6% of predicted and a mean DLCO of 85.5 ± 20.1%. Adenocarcinoma was the most common histologic type (46.7%), followed by squamous cell (16.7%) and small cell (16.7%). Most patients were diagnosed at an advanced stage (65% in stages III-IV). The vast majority (80%) had OSA (apnea-hypopnea index [AHI] > 5), and 50% had moderate to severe OSA (AHI > 15) with a mean Epworth Sleepiness Score of 7.43 ± 3.85. Significant nocturnal hypoxemia was common (Median T90: 10.9% interquartile range 2.4-42.2). CONCLUSIONS: Sleep apnea and nocturnal hypoxemia are highly prevalent in patients with lung cancer.


Subject(s)
Lung Neoplasms/complications , Sleep Apnea Syndromes/complications , Adenocarcinoma/complications , Aged , Carcinoma, Small Cell/complications , Carcinoma, Squamous Cell/complications , Cross-Sectional Studies , Female , Humans , Hypoxia/complications , Male , Prospective Studies , Pulmonary Disease, Chronic Obstructive/complications , Severity of Illness Index
3.
Arch. bronconeumol. (Ed. impr.) ; 45(6): 304-305, jun. 2009. graf
Article in Spanish | IBECS | ID: ibc-74189

ABSTRACT

Las neumonitis por hipersensibilidad (NH) pueden producirse debido a la exposición a hongos ambientales por contaminación de humidificadores y sistemas de calefacción. Describimos el caso de una paciente que acudió a urgencias por disnea, tos, dolor torácico y fiebre. Presentaba infiltrados intersticiales en la radiografía de tórax y leucocitosis con neutrofilia e hipoxemia grave en la analítica sanguínea. La combinación de exploraciones clínicas, radiológicas, fisiológicas e inmunológicas llevó al diagnóstico de NH. Tenía un humidificador doméstico en casa desde hacía un año. En el cultivo de las muestras de agua del humidificador crecióTrichoderma viride. Se detectaron anticuerpos precipitantes inmunoglobulina G anti T. viride mediante enzimoinmunoanálisis en el suero de la paciente. Tras retirar el humidificador la paciente permaneció asintomática. El resultado de los estudios indica que desarrolló NH causada por T. viride que contaminaba el agua del humidificador. Según nuestro conocimiento, éste es el primer caso descrito de NH por T. viride(AU)


Hypersensitivity pneumonitis (HP) can be induced by exposure to indoor molds contaminating humidifiers and heating or ventilation systems. A 54-year-old woman with dyspnea, cough, chest pain, and fever was seen in the emergency room. A chest radiograph revealed interstitial infiltrates and blood tests showed leukocytosis with neutrophilia and severe hypoxemia. A diagnosis of HP was made by a combination of clinical, radiologic, physiologic, and immunologic studies. Trichoderma viride was isolated in cultures of water samples from an ultrasonic humidifier installed in the patient's home a year earlier. Precipitating immunoglobulin G antibodies to T viride were detected in the patient's serum by enzyme-linked immunosorbent assay. The patient remained symptom free after the humidifier was removed from her home. Our findings strongly suggest that the patient developed HP due to T viride from the humidifier. To our knowledge, this is the first report of such a case(AU)


Subject(s)
Humans , Female , Middle Aged , Alveolitis, Extrinsic Allergic/complications , Alveolitis, Extrinsic Allergic/diagnosis , Trichoderma/virology , Trichoderma/pathogenicity , Trichoderma/isolation & purification , Equipment Contamination , Air Conditioning/instrumentation , Dyspnea , Fungi
4.
Arch Bronconeumol ; 45(6): 304-5, 2009 Jun.
Article in Spanish | MEDLINE | ID: mdl-19442428

ABSTRACT

Hypersensitivity pneumonitis (HP) can be induced by exposure to indoor molds contaminating humidifiers and heating or ventilation systems. A 54-year-old woman with dyspnea, cough, chest pain, and fever was seen in the emergency room. A chest radiograph revealed interstitial infiltrates and blood tests showed leukocytosis with neutrophilia and severe hypoxemia. A diagnosis of HP was made by a combination of clinical, radiologic, physiologic, and immunologic studies. Trichoderma viride was isolated in cultures of water samples from an ultrasonic humidifier installed in the patient's home a year earlier. Precipitating immunoglobulin G antibodies to T viride were detected in the patient's serum by enzyme-linked immunosorbent assay. The patient remained symptom free after the humidifier was removed from her home. Our findings strongly suggest that the patient developed HP due to T viride from the humidifier. To our knowledge, this is the first report of such a case.


Subject(s)
Air Conditioning/instrumentation , Alveolitis, Extrinsic Allergic/etiology , Equipment Contamination , Trichoderma , Water Microbiology , Alveolitis, Extrinsic Allergic/diagnosis , Alveolitis, Extrinsic Allergic/immunology , Alveolitis, Extrinsic Allergic/therapy , Anti-Bacterial Agents/therapeutic use , Antibodies, Fungal/blood , Bronchodilator Agents/therapeutic use , Combined Modality Therapy , Dyspnea/etiology , Emergencies , Female , Humans , Immunoglobulin G/blood , Middle Aged , Oxygen Inhalation Therapy , Respiration, Artificial , Trichoderma/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...